Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| CEO | | 2.71M | $49.77M | - |
| CEO | ROBINS CHAD M | 2.58M | $47.47M | -124,998 |
| Other | | 1.23M | $22.64M | - |
| Other | ROBINS HARLAN S | 1.22M | $22.45M | -10,000 |
| COO | RUBINSTEIN JULIE | 607.7K | $11.16M | - |
Transactions
50 transactions · page 15
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2020-06-19 | BENZENO SHARON | Chief Business Development Off | Sale+OE | 417 | $45.00 | $18,765.00 | -100% | → |
| 2020-06-19 | ROBINS CHAD M | CEO and Chairman | Sale+OE | 69,680 | $44.57 | $3,105,911.60 | -0.8% | → |
| 2020-06-18 | LO FRANCIS | Chief People Officer | Sale+OE | 2,000 | $44.34 | $88,680.00 | -100% | → |
| 2020-06-15 | HERSHBERG ROBERT | Director | Sale+OE | 2,000 | $43.00 | $85,996.72 | -67.0% | → |
| 2020-06-09 | BALDO LANCE | Chief Medical Officer | Sale+OE | 6,250 | $39.67 | $247,968.17 | -76.1% | → |
| 2020-06-09 | Cohen Chad M | Chief Financial Officer | Sale+OE | 30,000 | $39.35 | $1,180,517.95 | -84.6% | → |
| 2020-06-03 | BENZENO SHARON | Chief Business Development Off | Sale+OE | 6,770 | $40.00 | $270,800.00 | -100% | → |
| 2020-06-03 | DOBMEIER ERIC | Director | Sale+OE | 5,000 | $39.79 | $198,950.00 | -100% | → |
| 2020-05-26 | Taylor Stacy L | SVP and General Counsel | Sale+OE | 2,880 | $42.00 | $120,960.00 | -68.9% | → |
| 2020-05-26 | BENZENO SHARON | Chief Business Development Off | Sale+OE | 416 | $42.00 | $17,472.00 | -100% | → |
| 2020-05-21 | ROBINS CHAD M | CEO and Chairman | Sale+OE | 150,000 | $40.23 | $6,034,424.00 | -1.9% | → |
| 2020-05-20 | ROBINS HARLAN S | Chief Scientific Officer | Sell | 70,000 | $40.28 | $2,819,307.64 | -68.1% | → |
| 2020-05-19 | Cohen Chad M | Chief Financial Officer | Sale+OE | 50,000 | $40.00 | $2,000,000.00 | -98.0% | → |
| 2020-05-19 | DOBMEIER ERIC | Director | Sale+OE | 5,000 | $40.00 | $200,000.00 | -100% | → |
| 2020-05-19 | BENZENO SHARON | Chief Business Development Off | Sale+OE | 246,770 | $40.00 | $9,870,800.00 | -100% | → |
| 2020-05-18 | ROBINS HARLAN S | Chief Scientific Officer | Sale+OE | 77,700 | $36.85 | $2,863,364.64 | -9.0% | → |
| 2020-05-15 | HERSHBERG ROBERT | Director | Sale+OE | 2,000 | $34.75 | $69,496.08 | -62.6% | → |
| 2020-05-15 | SANG CHARLES | SVP, Clinical Diagnostics | Sale+OE | 40,000 | $38.01 | $1,520,400.00 | -100% | → |
| 2020-05-12 | RUBINSTEIN JULIE | President | Sale+OE | 110,000 | $38.10 | $4,190,780.20 | -95.5% | → |
| 2020-05-08 | Cohen Chad M | Chief Financial Officer | Sale+OE | 20,000 | $35.92 | $718,400.00 | -95.2% | → |
| 2020-05-07 | ROBINS CHAD M | CEO and Chairman | Sale+OE | 45,000 | $35.60 | $1,601,967.24 | -1.2% | → |
| 2020-05-07 | DOBMEIER ERIC | Director | Sale+OE | 5,000 | $35.00 | $175,000.00 | -100% | → |
| 2020-05-06 | BALDO LANCE | Chief Medical Officer | Sale+OE | 50,000 | $33.86 | $1,692,885.00 | -98.9% | → |